Cargando…

Second-dose mRNA COVID-19 vaccine safety in patients with immediate reactions after the first dose: A case series

BACKGROUND: The rates of suspected allergic reactions to the first dose of the coronavirus disease 2019 (COVID-19) mRNA vaccines have been reported to be as high as 2%, with an anaphylaxis incidence up to 2.5 per 10,000 individuals. Anaphylaxis in response to the first dose may be considered a contr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iaboni, Aled, Jindal, Nina, Betschel, Stephen D., Song, Christine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010013/ https://www.ncbi.nlm.nih.gov/pubmed/36203478 http://dx.doi.org/10.1016/j.jacig.2022.03.003

Ejemplares similares

Administration of the Second Dose of mRNA COVID-19 Vaccine to a Woman With Immediate Reaction to the First Dose
por: Apostolidou, Evaggelia, et al.
Publicado: (2023)

Safety and efficacy of graded dosing of Pfizer-BioNTech mRNA COVID-19 vaccine after an immediate hypersensitivity reaction to first dose
por: Regula, Prudhvi, et al.
Publicado: (2022)

Graded Administration of Second Dose of Moderna and Pfizer-BioNTech COVID-19 mRNA Vaccines in Patients With Hypersensitivity to First Dose
por: Tuong, Linh-An C, et al.
Publicado: (2021)

Impact of lanadelumab in hereditary angioedema: a case series of 12 patients in Canada
por: Iaboni, Aled, et al.
Publicado: (2021)

Immediate Reactions After the First Dose of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Messenger RNA Vaccines Do Not Preclude Second-Dose Administration
por: Vanijcharoenkarn, Kristine, et al.
Publicado: (2021)

Adverse Reactions of the Second Dose of the BNT162b2 mRNA COVID-19 Vaccine in Healthcare Workers in Korea
por: Lee, Yun Woo, et al.
Publicado: (2021)

Safety and reactogenicity of second booster doses for mRNA vaccines
por: Wilder-Smith, Annelies, et al.
Publicado: (2023)

A Patient with X-Linked Agammaglobulinemia and COVID-19 Infection Treated with Remdesivir and Convalescent Plasma
por: Iaboni, Aled, et al.
Publicado: (2021)

Clinical Phenotypes of Immediate First-Dose Reactions to mRNA COVID-19: A Multicenter Latent Class Analysis
por: Stone, Cosby A., et al.
Publicado: (2023)

Investigating two versus three doses of mRNA vaccine in patients with cirrhosis
por: Hindson, Jordan
Publicado: (2022)

Graded-dosing immunization in adults at risk for immediate-type reactions to mRNA SARS-CoV-2 vaccines
por: Stehlin, Florian, et al.
Publicado: (2023)

Delayed skin reactions after the second dose of mRNA vaccines against SARS-CoV-2
por: Martins-Filho, Paulo Ricardo, et al.
Publicado: (2022)

How important is the second dose of the COVID-19 mRNA vaccine?
por: Liu, Anne Y.
Publicado: (2021)

Immediate reactions after mRNA SARS-CoV-2 vaccination
por: Jeimy, Samira, et al.
Publicado: (2021)

Immunogenicity and Safety of a Third COVID-19 BNT162b2 mRNA Vaccine Dose in 5- to 11-Year Olds
por: Simões, Eric A F, et al.
Publicado: (2023)

Heterologous Ad.26.COV2.S versus homologous BNT162b2/mRNA-1273 as a third dose in solid organ transplant recipients seronegative after two-dose mRNA vaccination
por: Chiang, Teresa PY, et al.
Publicado: (2022)

Fulminant myocarditis after the second dose of COVID‐19 mRNA vaccination
por: Oka, Akihiro, et al.
Publicado: (2022)

Reply to “How important is the second dose of the COVID-19 mRNA vaccine?”
por: Shaker, Marcus S., et al.
Publicado: (2021)

Delayed Hypersensitivity Reactions Following First Dose of the SARS-CoV2 mRNA Vaccines
por: Xu, Jennifer, et al.
Publicado: (2021)

Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept
por: Chavarot, Nathalie, et al.
Publicado: (2021)

First-Dose Antimicrobial Infusion Reactions in Patients Enrolled in Outpatient Parenteral Antimicrobial Therapy Services
por: Kovacik, Carrie N, et al.
Publicado: (2023)

Reports of acute adverse events in mRNA COVID-19 vaccine recipients after the first and second doses in Japan
por: Akaishi, Tetsuya, et al.
Publicado: (2022)

Association between Adverse Reactions to the First and Second Doses of COVID-19 Vaccine
por: Goda, Ken, et al.
Publicado: (2022)

The Importance of a Timely Second Dose of the 2021 COVID-19 mRNA Vaccine Depends on the Protection Afforded by a First Dose and Subsequent Risk of Anaphylaxis
por: Shaker, Marcus, et al.
Publicado: (2021)

First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing
por: Wolfson, Anna R., et al.
Publicado: (2021)

Impact of methotrexate on first-dose COVID-19 mRNA vaccination
por: Connolly, Caoilfhionn M, et al.
Publicado: (2021)

Promising Efficacy of a Third Dose of mRNA SARS-CoV-2 Vaccination in Patients Treated with Anti-CD20 Antibody Who Failed 2-Dose Vaccination
por: Funakoshi, Yohei, et al.
Publicado: (2022)

Asymptomatic SARS-CoV-2 infection following first dose mRNA-1273 COVID-19 vaccine in a veterans affairs long term care facility
por: Fisher, Matthew J., et al.
Publicado: (2021)

What a second booster dose of mRNA COVID-19 vaccines tells us
por: Loubet, Paul, et al.
Publicado: (2022)

Immunogenicity of Third-dose BNT162b2 mRNA Vaccine Following Two Doses of ChAdOx1 in Health Care Workers: A Prospective Longitudinal Study
por: Kim, Jung-Ah, et al.
Publicado: (2022)

Second-dose COVID-19 vaccines are well tolerated in patients with allergic reactions to the first dose – a single center experience
por: Puxkandl, Viktoria, et al.
Publicado: (2022)

Livedoid skin reaction to 2nd dose of mRNA Covid-19 vaccine
por: Girolami, Ilaria, et al.
Publicado: (2022)

Serologic response to a third dose of an mRNA-based SARS-CoV-2 vaccine in lung transplant recipients
por: Hoffman, T.W., et al.
Publicado: (2022)

Antibody Kinetics after Three Doses of SARS-CoV-2 mRNA Vaccination in Patients with Inflammatory Bowel Disease
por: Tsipotis, Evangelos, et al.
Publicado: (2023)

High–temporal resolution profiling reveals distinct immune trajectories following the first and second doses of COVID-19 mRNA vaccines
por: Rinchai, Darawan, et al.
Publicado: (2022)

Alternate-day dosing of linagliptin in type 2 diabetes patients controlled on once daily dose: A case series
por: Baruah, Manash P., et al.
Publicado: (2016)

Dermoscopic Characterization of Zoon Balanitis: First Case Series from Asia
por: Chauhan, Payal, et al.
Publicado: (2022)

Multisystem Inflammatory Syndrome in Adult after First Dose of mRNA Vaccine
por: Miyazato, Yusuke, et al.
Publicado: (2022)

Acute Myocarditis Following Vaccination With the First Dose of the mRNA-1273 Vaccine
por: Olagunju, Abdulbaril, et al.
Publicado: (2022)

The Prevalence of Immediate Hypersensitivity Reactions to the BNT162b2 mRNA Vaccine against SARS-CoV-2: Data from the Vaccination Campaign in a Large Academic Hospital
por: Paoletti, Giovanni, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2g5mb7hpq9cdcn21cqju32bogr